FIELD: biotechnologies.
SUBSTANCE: disclosed is a method of producing siRNA/liposomal vector complexes for experiments in vivo.
EFFECT: high homogeneity of the obtained complexes with higher concentration of initial reagents.
1 cl, 5 dwg, 3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
SIRNA-BASED COMPOSITION FOR INHIBITING Gal-9 (LGALS9), PREPARATION BASED THEREON AND METHOD OF USING IT AS TARGETED IMMUNOSTIMULANT IN ANTI-PD-L1 THERAPY | 2023 |
|
RU2832798C1 |
LIPOSOME FORMULATIONS | 2013 |
|
RU2680096C2 |
LIPOSOMAL PREPARATIONS | 2013 |
|
RU2817350C2 |
LIPOSOMAL COMPOSITION AND PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2734900C1 |
LIPOSOMAL COMPOSITION | 2010 |
|
RU2476216C1 |
LIPOSOMAL ANTITUMOR COMPOSITIONS | 2017 |
|
RU2756837C2 |
METHOD OF OBTAINING LIPOSOMAL MICRONUTRIENTS | 2022 |
|
RU2805756C1 |
METHOD OF LIPOSOMAL COMPOSITION PREPARING (VARIANTS) | 1995 |
|
RU2104691C1 |
METHOD OF PRODUCING LIPOSOMAL COSMETIC SERUM IN DRY LYOPHILIZED FORM FOR FACE, NECK AND CLEAVAGE SKIN CARE | 2023 |
|
RU2825130C1 |
IMPROVED LIPOSOMAL COMPOSITIONS OF LIPOPHILIC COMPOUNDS | 2011 |
|
RU2641605C2 |
Authors
Dates
2025-04-22—Published
2024-10-23—Filed